Pediatric neurological syndromes and inborn errors of purine metabolism

Neurochemistry International

Volumn 56, Issue 3, 2010, Pages 367-378

  Camici, Marcella ^a   Micheli, Vanna ^b   Ipata, Piero Luigi ^a   Tozzi, Maria Grazia ^a  

^a Dipartimento di Biologia   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

5 Nucleotidase; 5 Amino 4 imidazolecarboxamide ribotide transformylase IMP cyclohydrolase; Adenosine deaminase; Adenylosuccinate lyase; Deoxyguanosine kinase; Hypoxanthine guanine phosphoribosyltransferase; Neurological syndromes; Phosphoribosylpyrophosphate synthetase; Purine dismetabolisms; Purine nucleoside phosphorylase

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DEAMINASE; ADENYLOSUCCINATE LYASE; DEOXYGUANOSINE KINASE; HYDROLASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INOSINE PHOSPHATE CYCLOHYDROLASE; PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE; PURINE NUCLEOSIDE PHOSPHORYLASE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; UNCLASSIFIED DRUG;

CHILD HEALTH; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GENETIC DISORDER; HUMAN; INBORN ERROR OF METABOLISM; MENTAL DISEASE; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; PURINE METABOLISM; REVIEW; SYMPTOMATOLOGY;

AGE FACTORS; BRAIN DISEASES, METABOLIC, INBORN; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; ENZYMES; HUMANS; INFANT; INFANT, NEWBORN; METABOLIC NETWORKS AND PATHWAYS; NEURONS; NUCLEOTIDES; PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS; PURINES;

EID: 77049116036     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.12.003     Document Type: Review

References (137)

1. Abbud W., Habinowsky S., Zhang J.Z., Kendrew J., Elkairi F.S., Kemp B.E., Witters L.A., Ismail-Beigi F. Stimulation of AMP-activated protein kinase is associated with enhancement of Glut1-mediated glucose transport. Arch. Biochem. Biophys. 2000, 380:347-352.
2. Adams A., Harkness A. Developmental changes in purine phosphoribosyltransferases in human and rat tissues. Biochem. J. 1976, 160:565-576.
3. Ahmed M., Taylor W., Smith P.R., Becker M.A. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase. J. Biol. Chem. 1999, 274:7482-7488.
4. Alexiou M., Leese H.J. Purine utilisation, de novo synthesis and degradation in mouse preimplantation embryos. Development 1992, 114:185-192.
5. Anderson L.T., Ernst M. Self-injury in Lesch-Nyhan disease. J. Autism Dev. Disord. 1994, 24:67-81.
6. Anderson L.T., Ernst M., Davis S.V. Cognitive abilities of patients with Lesch-Nyhan disease. J. Autism Dev. Disord. 1992, 22:189-203.
7. Aral B., de Saint Basile G., Al-Garawi S., Kamoun P., Ceballos-Picot I. Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient. Hum. Mutat. 1996, 7:52-58.
8. Arpaia E., Benveniste P., Di Cristofano A., Gu Y., Dalal I., Kelly S., Hershfield M., Pandolfi P.P., Roifman C.M., Cohen A. Mitochondrial basis for immune deficiency: evidence from purine nuceloside phosphorylase-deficient mice. J. Exp. Med. 2000, 191:2197-2207.
9. Bavaresco C.S., Chiarani F., Wannmacher C.M., Netto C.A., Wyse A.T. Intrastriatal hypoxanthine reduces Na(+), K(+)-ATPase activity and induces oxidative stress in the rats. Metab. Brain Dis. 2007, 22:1-11.
10. Becker M.A. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. J. Clin. Investig. 1976, 57:308-318.
11. Becker M.A., Heidler S.A., Bell G.I., Seino S., LeBeau M.M., Westbrook C.A., Neuman W., Shapiro L.J., Mohandas T.K., Roessler B.J., Palella D. Cloning of cDNAs for human phosphoribosylpyrophosphate synthetase 1 and 2 and X chromosome localization of PRPS1 and PRPS2 genes. Genomics 1990, 8:550-561.
12. Becker M.A., Losman M.J., Kim M. Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetase. J. Biol. Chem. 1987, 262:5596-5602.
13. Becker M.A., Losman M.J., Wilson J., Simmonds H.A. Superactivity of phosphoribosylpyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate. Biochim. Biophys. Acta 1988, 882:168-176.
14. Becker M.A., Puig J.G., Mateos F.A., Jimenez M.L., Kim M., Simmonds A. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorial deafness. Am. J. Med. 1988, 85:383-390.
15. Becker M.A., Raivio K.O., Bakay B., Adams W.B., Nyhan W.L. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions. J. Clin. Investig. 1980, 65:109-120.
16. Becker M.A., Smithy P.R., Taylor W., Mustafi R., Switzer R.L. The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity. J. Clin. Investig. 1995, 96:2133-2141.
17. Becker M.A., Taylor W., Smith P.R., Ahmed M. Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase. J. Biol. Chem. 1996, 271:19894-19899.
18. Benveniste P., Cohen A. p53 expression is required for thymocyte apoptosis induced by adenosine deaminase deficiency. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:8373-8377.
19. Bertelli M., Cecchin S., Lapucci C., Jacomelli G., Jinnah H.A., Pandolfo M., Micheli V. Study of the adenosinergic system in the brain of HPRT knockout mouse (Lesch-Nyhan disease). Clin. Chim. Acta 2006, 373:104-107.
20. Bianchi V., Spychala J. Mammalian 5′-nucleotidases. J. Biol. Chem. 2003, 278:46195-46198.
21. Bollinger M.E., Arredondo Vega F.X., Santisteban I., Schwarz K., Hershfield M.S., Lederman H.M. Hepatic dysfunction as a complication of adenosine deaminase deficiency. N. Engl. J. Med. 1996, 334:1367-1371.
22. Breese G.R., Criswell H.E., Duncan G.E., Mueller R.A. A dopamine deficiency model of Lesch-Nyhan disease-the neonatal-6-OHDA-lesioned rat. Brain Res. Bull. 1990, 25:477-484.
23. Bzowska A., Kulikowska E., Shugar D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Therapeut. 2000, 88:349-425.
24. Careddu M.G., Allegrini S., Pesi R., Camici M., Garcia-Gil M., Tozzi M.G. Knockdown of cytosolic 5(-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells. Biochim. Biophys. Acta 2008, 1783:1529-1535.
25. Cederbaum S.D., Kaitila I., Rimoin D.L., Stiehm E.R. The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J. Pediatr. 1976, 89:737-742.
26. Chantin C., Bonin B., Boulieu R., Bory C. Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency. Clin. Chem. 1996, 42:326-328.
27. Cohen A., Gudas L.J., Ammann A.J., Staal G.E., Martin D.J. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency. J. Clin. Investig. 1978, 61:1405-1409.
28. Copeland W.C. Inherited mitochondrial diseases of DNA replication. Ann. Rev. Med. 2008, 59:131-146.
29. Corton J.M., Gillespie J.G., Hawley S.A., Hardie D.G. 5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating AMP-dependent protein kinase in intact cells?. Eur. J. Biochem. 1995, 229:558-565.
30. Crifò C., Siems W., Soro S., Salerno C. Inhibition of defective adenylosuccinate lyase by HNE: a neurological disease that may be affected by oxidative stress. Biofactors 2005, 24:131-136.
31. Criswell H., Mueller R.A., Breese G.R. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine. J. Pharmacol. Exp. Therapeut. 1988, 244:493-500.
32. Dalal I., Grunebaum E., Cohen A., Roifman C.M. Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient. Clin. Genet. 2001, 59:430-437.
33. De Brouwer A.P.M., Williams K.L., Duley J.A., van Kuilenburg A.B.P., Nabuurs S.B., Egmont-Petersen M., Lugtenberg D., Zoetekouw L., Banning M.J.G., Roeffen M., Hamel B.C.J., Weaving L., Ouvrier R.A., Donald J.A., Wevers R.A., Christodoulou J., van Bokhoven H. Arts syndrome is caused by loss-of-function mutations in PRPS1. Am. J. Hum. Genet. 2007, 81:507-518.
34. De Gregorio L., Jinnah H.A., Harris J.C., Nyhan W.L., Schretlen D.J., Trombley L.M., O'Neill J.P. Lesch-Nyhan disease in a female with a clinically normal monozygotic twin. Mol. Genet. Metab. 2005, 85:70-77.
35. De Volder A.G., Jaeken J., Van den Berghe G., Bol A., Michel C., Cogneau M., Goffinet A.M. Regional brain glucose utilization in adenylosuccinase-deficient patients measured by positron emission tomography. Pediatr. Res. 1988, 24:238-242.
36. Ducluzeau P.-H., Lachaux A., Bouvier R., Duborjal H., Stepien G., Bozon D., Mousson de Camaret B. Progressive reversion of clinical and molecular phenotype in a child with liver mitochondrial DNA depletion. J. Hepatol. 2002, 36:698-703.
37. Elpeleg O., Mandel H., Saada A. Depletion of the other genome-mitochondrial DNA depletion syndromes in humans. J. Mol. Med. 2002, 80:389-396.
38. Eriksson S., Munch-Petersen B., Johansson K., Eklund H. Structure and function of cellular deoxyribonucleoside kinases. Cell. Mol. Life Sci. 2002, 59:1327-1346.
39. Eriksson S., Wang L. Molecular mechanisms of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism. Nucleosides Nucleotides Nucleic Acids 2008, 27:800-808.
40. Fairbanks L.D., Jacomelli G., Micheli V., Slade T., Simmonds H.A. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. Biochem. J. 2002, 366:265-272.
41. Fox I.H., Kelley W.N. Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition. J. Biol. Chem. 1972, 247:2126-2131.
42. Garcia-Gil M., Bertini F., Pesi R., Voccoli V., Tozzi M.G., Camici M. 5′-Amino-4-imidazolecarboxamide riboside induces apoptosis in human neuroblastoma cells via the mitochondrial pathway. Nucleosides Nucleotides Nucleic Acids 2006, 25:1265-1270.
43. Garcia-Gil M., Pesi R., Perna S., Allegrini S., Giannecchini M., Camici M., Tozzi M.G. 5′-Aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells. Neuroscience 2003, 117:811-820.
44. Giblett E.R., Amman A.J., Wara D.W., Diamond L.K. Nucleoside phosphorylase deficiency in a child with severely defective T cell immunity and normal B cell immunity. Lancet 1975, 1:1010-1013.
45. Henderson J.F., Brox L.W., Kelley W.N., Rosenbloom F.M., Seegmiller J.E. Kinetic studies of hypoxanthine-guanine phosphoribosyl transferase. J. Biol. Chem. 1968, 243:2514-2522.
46. Henin N., Vincent M.F., Gruber H.E., Van den Berghe G. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J. 1995, 9:541-546.
47. Hershfield M.S. Immunodeficiency caused by adenosine deaminase deficiency. Immunol. Allergy Clin. N. Am. 2001, 20:161-175.
48. Hirschhorn R., Papageorgiou P.S., Kesarwala H.H. Amelioration of neurological abnormalities after enzyme replacement in adenosine deaminase deficiency. N. Engl. J. Med. 1980, 303:377-380.
49. Hirschhorn R. Adenosine deaminase deficiency. Immunodefic. Rev. 1990, 2:175-198.
50. Hirschhorn R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Pediatr. Res. 1993, 33:35-41.
51. Hirschhorn R., Roegner-Maniscalco V., Kuritsky L., Rosen F.S. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine-deficient patients. J. Clin. Investig. 1981, 68:1387-1393.
52. Holmes B.F., Kurth-Kraczek E.J., Winder W.W. Chronic activation of 5′-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 1999, 87:1990-1995.
53. Holmes E.W., McDonald J.A., McCord J.M., Wyngaarden J.B., Kelley W.N. Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulation properties. J. Biol. Chem. 1973, 248:144-150.
54. Hunsucker S.A., Mitchell B.S., Spychala J. The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol. Therapeut. 2005, 107:1-30.
55. Ipata P.L., Tozzi M.G. Recent advances in structure and function of cytosolic IMP-GMP specific 5′-nucleotidase II (cN-II). Purinergic Signall. 2006, 2:669-675.
56. Jacomelli G., Micheli V., Peruzzi L., Notarantonio L., Cerboni B., Sestini S., Pompucci G. Simple non-radiochemical HPLC-linked method for screening for purine metabolism disorders using dried blood spots. Clin. Chim. Acta 2002, 324:135-139.
57. Jaeken J., Van den Berghe G. An infantile autistic syndrome characterised by the presence of succinylpurines in body fluid. Lancet 1984, 2:1058-1061.
58. Jankovic J., Caskey C.T., Stout J.T., Butler I.J. Lesch Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann. Neurol. 1988, 23:466-469.
59. Jinnah H.A., De Gregorio L., Harris J.C., Nyhan W.L., O'Neill J.P. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat. Res. 2000, 463:309-326.
60. Jinnah H.A., Friedmann T. Lesch-Nyhan disease and its variants. The Metabolic and Molecular Basis of Inherited Disease 2000, 2537-2570. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
61. Jinnah H.A., Harris J.C., Nyhan W.L., O'Neill J.P. The spectrum of mutations causing HPRT deficiency: an update. Nucleosides Nucleotides Nucleic Acids 2004, 23:1153-1160.
62. Jinnah H.A., Jones M.D., Wojcik B.E., Rothstein J.D., Hess E.J., Friedmann T., Breese G.R. Influence of age and strain on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. J. Neurochem. 1999, 72:225-229.
63. Jinnah H.A., Visser J.E., Harris J.C., Verdu A., Larovere L., Ceballos-Picot I., Gonzalez-Alegre P., Neychev V., Torres R.J., Dulac O., Desguerre I., Schretlen D.J., Robey K.L., Barabas G., Bloem B.R., Nyhan W., De Kremer R., Eddey G.E., Puig J.G., Reich S.G. Delineation of the motor disorder of Lesch-Nyhan disease. Brain 2006, 129:1201-1217.
64. Jinnah H.A., Wojcik B.E., Hunt M., Narang N., Lee K.Y., Golstein M., Wamsley J.K., Langlais P.J., Friedmann T. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J. Neurosci. 1994, 14:1164-1175.
65. Johansson M., Bajalica-Lagercrantz S., Lagercrantz J., Karlsson A. Localization of the human deoxyguanosine kinase gene (DGUOK) to chromosome 2p13. Genomics 1996, 38:450-451.
66. Kelley W.N., Greene M.L., Rosenbloom F.M., Henderson J.F., Seegmiller J.E. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann. Intern. Med. 1969, 70:155-206.
67. Kim H.-J., Sohn K.-M., Shy M.E., Krajewski K.M., Hwang M., Park J.-H., Jang S.-Y., Won H.-H., Choi B.-O., Hong S.H., Kim B.-J., Suh Y.-L., Ki C.-S., Lee S.-Y., Kim S.-H., Kim J.-W. Mutations in PRPS1, which encodes the phosphoribosyl pyrophosphate synthetase enzyme critical for nucleotide biosynthesis, cause hereditary peripheral neuropathy with hearing loss and optic neuropathy (CMTX5). Am. J. Hum. Genet. 2007, 81:552-558.
68. Labarthe F., Dobbelaere D., Devisme L., De Muret A., Jardel C., Taanman J.-W., Gottrand F., Lombès A. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency. J. Hepatol. 2005, 43:333-341.
69. Laikind P.K., Seegmiller J.E., Gruber H.E. Detection of 5′-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity. Analyt. Biochem. 1986, 156:81-90.
70. Leanza L., Ferraro P., Reichard P., Bianchi V. Metabolic interrelations within guanine deoxynucleotide pools for mitochondrial and nuclear DNA maintenance. J. Biol. Chem. 2008, 283:16437-16445.
71. Lloyd K.G., Hornykiewicz O., Davidson L., Shannak K., Farley I., Goldstein M., Shibuya M., Kelley W.N., Fox I.H. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Engl. J. Med. 1981, 305:1106-1111.
72. Mandel H., Szargel R., Labay V., Elpeleg O., Saada A., Shalata A., Anbinder Y., Berkowitz D., Hartman C., Barak M., Eriksson S., Cohen N. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat. Genet. 2001, 29:337-341.
73. Marie S., Heron B., Bitoun P., Timmerman T., Van den Berghe G., Vincent M.F. AICA ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am. J. Hum. Genet. 2004, 74:1276-1281.
74. Markert M.L. Purine nucleoside phosphorylase deficiency. Immunodefic. Rev. 1991, 3:45-81.
75. Markert M.L. Purine nucleoside phosphorylase deficiency. Immunodeficiencies 1993, 197-224. Harwood Academic Publisher, Switzerland. F.S. Rosen (Ed.).
76. Matthews W.S., Solan A., Barabas G., Robey K. Cognitive functioning in Lesch-Nyhan syndrome: a 4-year follow-up study. Dev. Med. Child Neurol. 1999, 41:260-262.
77. Micheli V., Sestini S., Rocchigiani M., Jacomelli G., Manzoni F., Peruzzi L., Gathof B.S., Zammarchi E., Pompucci G. Hypoxanthine-guanine phosphoribosyltransferase deficiency and erythrocyte synthesis of pyridine coenzymes. Life Sci. 1999, 64:2479-2487.
78. Mohamedali K.A., Guicheri O.M., Kellems R.E., Rudolph F.B. The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J. Biol. Chem. 1993, 268:23728-23733.
79. Mousson de Camaret B., Taanman J.-W., Padet S., Chassagne M., Mayençon M., Clerc-Renaud P., Mandon G., Zabot M.-T., Lachaux A., Bozon D. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem. J. 2007, 402:377-385.
80. Nofech-Mozes Y., Blaser S.I., Kobayashi J., Grunebaum E., Roifman C.M. Neurologic abnormalities in patients with adenosine deaminase deficiency. Pediatr. Neurol. 2007, 37:218-221.
81. Nyhan W.L. Behavior in the Lesch-Nyhan syndrome. J. Autism Child. Schizophr. 1976, 6:235-352.
82. Nyhan W.L. Dopamine function in Lesch-Nyhan disease. Environ. Health Perspect. 2000, 108(Suppl. 3):409-411.
83. Nyhan W.L., Wong D.F. New approach to understanding Lesch-Nyhan disease. N. Engl. J. Med. 1996, 334:1602-1604.
84. Okada M., Nutt D.J., Murakami T., Zhu G., Kamata A., Kawata Y., Kaneko S. Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J. Neurosci. 2001, 21:628-640.
85. Page T. Metabolic approaches to the treatment of autism spectrum disorders. J. Autism Dev. Disord. 2000, 30:463-469.
86. Page T., Yu A., Fontanesi J., Nyhan W.L. Developmental disorder associated with increased cellular nucleotidase activity. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:11601-11606.
87. Palenchar J.B., Colman R.F. Characterization of a mutant Bacillus subtilis adenylosuccinate lyase equivalent to mutant enzyme found in human adenylosuccinate lyase deficiency: asparagine 276 plays an important structural role. Biochemistry 2003, 42:1831-1841.
88. Palenchar J.B., Crocco J.M., Colman R.F. The characterization of mutant Bacillus subtilis adenylosuccinate lyases corresponding to severe human adenylosuccinate lyase deficiencies. Protein Sci. 2003, 12:1694-1705.
89. Pesi R., Camici M., Micheli V., Notarantonio L., Jacomelli G., Tozzi M.G. Identification of the nucleotidase responsible for the AMP hydrolysing hyperactivity associated with neurological and developmental disorders. Neurochem. Res. 2008, 33:59-65.
90. Pesi R., Micheli V., Jacomelli G., Peruzzi L., Camici M., Garcia-Gil M., Allegrini S., Tozzi M.G. Cytosolic 5′-nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan syndrome patients. Neuroreport 2000, 11:1827-1831.
91. Pinto C.S., Seifert R. Decreased GTP-stimulated adenylyl cyclase activity in HPRT-deficient human and mouse fibroblast and rat B103 neuroblastoma cell membranes. J. Neurochem. 2006, 96:454-459.
92. Pontarin G., Ferraro P., Håkansson, Thelander L., Reichard P., Bianchi V. p53R2-dependent ribonucleotide reduction provides deoxyribonucleotides in quiescent human fibroblasts in the absence of induced DNA damage. J. Biol. Chem. 2007, 282:16820-16828.
93. Prior C., Torres R.J., Puig J.G. Hypoxanthine decreases equilibrative type of adenosine transport in lymphocytes from Lesch-Nyhan patients. Eur. J. Clin. Investig. 2007, 37:905-911.
94. Puig J.G., Torres R.J., Mateos F.A., Ramos T.H., Arcas J.M., Buno A.S., O'Neill P. The spectrum of HPRT deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine (Baltimore) 2001, 80:102-112.
95. Ratech H., Greco M.A., Gallo G., Rimoin D.L., Kamino H., Hirschhorn R. Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations. Am. J. Pathol. 1985, 120:157-169.
96. Ricciuti F., Ruddle F.H. Assignment of nucleoside phosphorylase to D-14 and localization of X-linked loci in man by somatic cell genetics. Nature 1973, 241:180-182.
97. Rinat C., Zoref-Shani E., Ben-Neriah Z., Bromberg Y., Becker-Cohen R., Feinstein S., Sperling O., Frishberg Y. Molecular, biochemical, and genetic characterization of a female patient with Lesch-Nyhan disease. Mol. Genet. Metab. 2006, 87:249-252.
98. Robey K.L., Reck J.F., Giacomini K.D., Barabas G., Eddey G.E. Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease. Dev. Med. Child Neurol. 2003, 45:167-171.
99. Rogers M.H., Lwin R., Fairbanks L., Gerritsen B., Gaspar H.B. Cognitive and behavioural abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J. Pediatr. 2001, 139:44-50.
100. Rossiter B.J.F., Caskey C.T. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout. The Metabolic and Molecular Basis of Inherited Disease 1995, 1679-1706. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
101. Saada A. Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell Biol. 2004, 23:797-806.
102. Saada A. Mitochondrial deoxynucleotide pools in deoxyguanosine kinase deficiency. Mol. Genet. Metab. 2008, 95:169-173.
103. Salerno C., D'Eufemia P., Finocchiaro R., Celli M., Spalice A., Iannetti P., Crifò C., Giardini O. Effect of d-ribose on purine synthesis and neurological symptoms in a patient with adenylosuccinase deficiency. Biochim. Biophys. Acta 1999, 1453:135-140.
104. Salerno C., Iotti R., Lodi R., Crifò C., Barbiroli B. Failure of muscle energy metabolism in a patient with adenylosuccinate lyase deficiency. An in vivo study by phosphorus NMR spectroscopy. Biochim. Biophys. Acta 1997, 1360:271-276.
105. Salviati L., Sacconi S., Mancuso M., Otaegui D., Camaño P., Marina A., Rabinowitz S., Shiffman R., Thompson K., Wilson C.M., Feigenbaum A., Naini A.B., Hirano M., Bonilla E., DiMauro S., Vu T.H. Mitochondrial DNA depletion and dGK gene mutations. Ann. Neurol. 2002, 52:311-317.
106. Schretlen D.J., Ward J., Meyer S.M., Yun J., Puig J.G., Nyhan W.L., Jinnah H.A., Harris J.C. Behavioral aspects of Lesch-Nyhan disease and its variants. Dev. Med. Child Neurol. 2005, 47:673-677.
107. Shirley T.L., Lewers J.C., Egami K., Majumdar A., Kelly M., Ceballos-Picot I., Seidman M.M., Jinnah H.A. A human neuronal tissue culture model for Lesch-Nyhan disease. J. Neurochem. 2007, 101:841-853.
108. Sidi Y., Mitchell B.S. Z-nucleotide accumulation in erythrocytes from Lesch-Nyhan patients. J. Clin. Investig. 1985, 76:2416-2419.
109. Simmonds H.A., Fairbanks L.D., Morris G.S., Webster D.R., Harley E.H. Altered erythrocyte nucleotide patterns are characteristic of inherited disorders of purine or pyrimidine metabolism. Clin. Chim. Acta 1988, 171:197-210.
110. Sivendran S., Patterson D., Spiegel E., McGown I., Cowley D., Colman R.F. Two novel mutant human adenylosuccinate lyases (ASLs) associated with autism and characterization of the equivalent mutant Bacillus subtilis ASL. J. Biol. Chem. 2004, 279:53789-53797.
111. Smith D.W., Friedmann T. Characterization of the dopamine defect in primary cultures of dopaminergic neurons from hypoxanthine phosphoribosyltransferase knockout mice. Mol. Ther. 2000, 1:486-491.
112. Song S., Friedman T. Tissue-specific aberrations of gene expression in HPRT-deficient mice: functional complexity in a monogenic disease?. Mol. Ther. 2007, 15:1432-1443.
113. Sperling O., Persky-Brosh S., Boer P., deVries A. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties. Biochem. Med. 1973, 7:389-395.
114. Spiegel E.K., Colman R.F., Patterson D. Adenylosuccinate lyase deficiency. Mol. Genet. Metab. 2006, 89:19-31.
115. Steyn L.M., Harley E.H. Substrate inhibition in a human variant of hypoxanthine-guanine phosphoribosyltransferase. J. Biol. Chem. 1984, 259:338-342.
116. Taanman J.-W., Muddle J.R., Muntau A.C. Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase deficient fibroblasts. Hum. Mol. Genet. 2003, 12:1839-1845.
117. Taira M., Iisaza T., Yamada K., Shimada H., Tatibana M. Tissue-differential expression of two distinct genes for phosphoribosyl pyrophosphate synthetase and existence of the testis-specific transcript. Biochim. Biophys. Acta 1989, 1007:203-208.
118. Takeda E., Kuroda Y., Naito E., Yokota I., Saijo T., Hirose M., Miyao M. Effects of deoxyadenosine on ribonucleotide reductase in adenosine deaminase-deficient lymphocytes. J. Inherit. Metab. Dis. 1991, 14:87-95.
119. Tozzi M.G., Camici M., Mascia L., Sgarrella F., Ipata P.L. Pentose phosphates in nucleoside interconversion and catabolism. FEBS J. 2006, 273:1089-1101.
120. Trifilo M., Page T. NAPDD patients exhibit altered electrophoretic mobility of cytosolic 5′-nucleotidase. Adv. Exp. Med. Biol. 2000, 486:87-90.
121. Van den Bergh F., Vincent M.F., Jaeken J., Van den Berghe G. Functional studies in fibroblasts of adenylosuccinase-deficient children. J. Inherit. Metab. Dis. 1993, 16:425-434.
122. Van den Bergh F., Vincent M.F., Jaeken J., Van den Berghe G. Residual adenylosuccinase activities in fibroblasts of adenylosuccinase-deficient children: parallel deficiency with adenylosuccinate and succinyl-AICAR in profoundly retarded patients and non-parallel deficiency in mildly retarded girl. J. Inherit. Metab. Dis. 1993, 16:415-424.
123. Van den Berghe G., Bontemps F., Vincent M.F., Van den Bergh F. The purine nucleotide cycle and its molecular defects. Prog. Neurobiol. 1992, 39:547-561.
124. Van den Berghe G., Jaeken J. Adenylosuccinase deficiency. Adv. Exp. Med. Biol. 1986, 195:27-33.
125. Vincent M.F., Bontemps F., Van den Berghe G. Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes. Biochem. J. 1992, 281:267-272.
126. Vincent M.F., Marangos P.J., Gruber H.E., Van den Berghe G. Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes. Diabetes 1991, 40:1259-1266.
127. Visser J.E., Bar P.R., Jinnah H.A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Rev. 2000, 32:449-475.
128. Wada Y., Nishimura Y., Tanabu M., Yoshimura Y., Iinuma K. Hypouricemic, mentally retarded infant with a defect of 5-phosphoribosyl-1-pyrophosphate synthetase of erythrocytes. Tohoku J. Exp. Med. 1974, 113:149-157.
129. Wang L., Eriksson S. Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome. FEBS Lett. 2003, 554:319-322.
130. Watts R.W., Spellacy E., Gibbs D.A., Allsop J., McKeran R.O., Slavin G.E. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the neurological manifestations. Q. J. Med. 1982, 51:43-78.
131. Williams S.R., Goddard J.M., Martin D.W. Human purine nucleoside phosphorylase cDNA and genomic clone characterization. Nucleic Acids Res. 1984, 12:5779-5787.
132. Wilson J.M., Baugher B.W., Landa L., Kelley W.N. Mutant form of hypoxanthine-guanine phosphoribosyltransferase. Purification and characterization of mutant form of the enzyme. J. Biol. Chem. 1981, 256:10306-10312.
133. Wilson J.M., Daddona P.E., Otoadese T., Kelley W.N. Adenine phosphoribosyltransferase in patients with disorders of purine and pyrimidine metabolism. J. Lab. Clin. Med. 1982, 99:163-174.
134. Wong D.F., Harris J.C., Naidu S., Yokoi F., Marenco S., Dannals R.F., Ravert H.T., Yaster M., Evans A., Rousset O., Bryan R.N., Gjedde A., Kuhar M.J., Breese G.R. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5539-5543.
135. Yoshida Y., Watanabe C., Matsuura M. A clinical study on the first case of purine nucleoside phosphorylase deficiency in Japan. Nippon Shonika Gakkai Zasshi (Tokyo) 1986, 90:2497-2502.
136. Zoref-Shani E., Boer P., Brosh S., Pelled D., Bromberg Y., Sperling O. Purine nucleotide metabolism in cultured neurons and astroglia from HPRT-deficient knockout mice. Ital. J. Biochem. 2001, 50:9-13.
137. Zoref-Shani E., Feinstein S., Frishberg Y., Bromberg Y., Sperling O. Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: reduced affinity for 5-phosphoribosyl-1-pyrophosphate manifested only at low, physiological substrate concentrations. Biochim. Biophys. Acta 2000, 1500:197-203.